News Center
For many couples and individuals considering in vitro fertilization, the first practical question is rarely medical—it is financial. IVF in the United States remains one of the most significant out-of-pocket healthcare expenses a family can face, and California, home to some of the most active fertility centers in the country, sits at the higher end of the national price range. This guide walks through what a full IVF cycle is expected to cost in California in 2026, which variables move the final number up or down, how insurance and financing can reduce the burden, and what to look for when comparing fertility clinics across Los Angeles, the San Francisco Bay Area, San Diego, Sacramento, and beyond.
A single standard IVF cycle in California typically ranges from $14,000 to $25,000 for the base procedure, before medications. When fertility medications are added—which they almost always are—the realistic all-in figure for one fresh cycle lands between $20,000 and $35,000. Patients who need genetic testing of embryos, intracytoplasmic sperm injection (ICSI), or additional monitoring should plan for the upper end of that spectrum or beyond.
These numbers are consistently higher than the national average, which generally falls between $12,000 and $18,000 for the base cycle. The difference reflects California's higher cost of living, elevated laboratory and staffing expenses, and the concentration of large, technology-heavy fertility programs in major metropolitan areas. Understanding where each dollar goes is the first step toward budgeting accurately.
| Service Component | Typical California Price Range (2026) |
|---|---|
| Initial consultation and fertility workup | $300 – $900 |
| Ovarian stimulation monitoring (ultrasounds, bloodwork) | $2,500 – $5,000 |
| Egg retrieval procedure | $4,000 – $8,000 |
| Anesthesia for retrieval | $600 – $1,500 |
| Embryo culture and laboratory fees | $2,000 – $5,000 |
| Embryo transfer (fresh or frozen) | $3,000 – $6,000 |
| Fertility medications (per cycle) | $3,000 – $8,000 |
| Preimplantation genetic testing (PGT-A), if used | $2,500 – $6,000 |
| Embryo freezing and first year of storage | $800 – $2,000 |
Keep in mind that these figures describe one complete cycle. Many patients require more than one transfer—sometimes more than one retrieval—before achieving a pregnancy, so the total cost of treatment should be planned as a multi-cycle journey rather than a single event.
First-time patients are often surprised to learn that injectable fertility medications can account for 30 to 40 percent of the total cycle cost. Gonadotropins such as Gonal-F, Follistim, and Menopur, along with trigger medications and progesterone support, are priced per dose, and a typical stimulation protocol may require 60 to 90 vials or pens over ten to fourteen days.
Patients with polycystic ovary syndrome (PCOS), diminished ovarian reserve, or those undergoing protocols designed to maximize egg yield may need higher doses, pushing medication bills toward $8,000 or more per cycle. Conversely, mini-IVF or low-stimulation protocols, sometimes recommended for older patients or those with low ovarian response, can cut medication costs significantly—often to $1,500 to $3,000—though these approaches involve trade-offs in cycle strategy that should be discussed with a reproductive endocrinologist.
The base cycle price quoted by a clinic rarely reflects everything a patient will actually use. The following services are the most common additions, each with its own price tag:
Budgeting tip: When requesting a quote from a California fertility clinic, ask specifically for a "cash price list" covering every item in a typical cycle, including anesthesia, monitoring, and lab fees. Some centers advertise a low headline price while billing monitoring and anesthesia separately, which can add $5,000 or more to the invoice.
Geography plays a measurable role in IVF pricing, which matters for patients searching locally. Understanding regional differences helps with both budgeting and travel decisions.
The Los Angeles metro area hosts one of the densest concentrations of fertility practices in the world, which creates genuine price competition. Base cycles in the region commonly run $15,000 to $22,000, with some large-volume practices offering multi-cycle packages that lower the per-cycle cost. The sheer number of options in LA, Orange County, and San Diego means patients can reasonably obtain quotes from three or four clinics within an hour's drive.
Bay Area clinics generally price at or above the state average, with full cycles frequently exceeding $25,000 once medications are included. Higher laboratory costs and real estate expenses contribute to this. Patients in Northern California sometimes compare Bay Area programs with Sacramento-based centers, where pricing can be somewhat lower while maintaining comparable technology.
San Diego's established programs price similarly to Los Angeles, while Sacramento, Fresno, and other inland cities often offer cycles at the more accessible end of the range, roughly $13,000 to $18,000 for the base procedure. Patients in these regions should weigh travel costs against savings; a $3,000 price difference can be eroded by repeated long-distance monitoring visits, though many clinics coordinate early monitoring with local OB-GYN offices or satellite locations.
California has historically been classified among states with limited mandated fertility coverage, but the landscape changed with SB 600, signed in 2023 and phased in through 2025 and 2026. Under this law, large-group health plans regulated by the state—generally those covering 100 or more employees—must cover infertility diagnosis and treatment, including up to three egg retrievals and unlimited embryo transfers within those retrievals, subject to medical necessity criteria. The mandate applies to state-regulated group plans; self-insured employer plans, which are governed by federal ERISA law rather than state insurance law, are not automatically included, and individual market plans have a later compliance timeline.
For patients, this means the single most valuable financial step in 2026 is a detailed benefits verification. Key questions to ask an insurance carrier or HR department:
Even partial coverage changes the equation dramatically. A plan that covers monitoring, anesthesia, and laboratory fees can reduce a patient's out-of-pocket cost by 40 to 60 percent, even if the cycle itself is excluded.
For patients paying out of pocket, several structured options exist beyond a simple credit card charge:
Many California clinics offer two- and three-cycle bundles priced at a discount of 20 to 30 percent versus paying cycle by cycle. Some include a partial refund if no live birth occurs after all included cycles. These programs suit patients with favorable prognoses who want cost predictability, though patients with significant barriers to success should read refund conditions carefully.
Companies such as Prosper Healthcare Lending, Future Family, and CapexMD provide dedicated fertility loans with fixed rates and terms ranging from 24 to 84 months. Some programs offer a grace period before repayment begins. Interest rates vary widely based on credit; comparing the annual percentage rate, not the monthly payment, is essential.
A growing number of California employers—particularly in technology, entertainment, and professional services—offer fertility benefits through platforms like Carrot Fertility, Progyny, and Maven. These benefits often provide a dollar allowance (commonly $15,000 to $50,000) or a benefit-token system that can be applied to IVF cycles. Employees changing jobs in 2026 should factor fertility benefits into their decision, since the difference between two offers can easily exceed the cost of an entire cycle.
Unreimbursed medical expenses exceeding 7.5 percent of adjusted gross income can be deducted on federal taxes for patients who itemize. IVF costs, medications, and travel to treatment are generally qualifying expenses. Keeping meticulous receipts throughout treatment makes this deduction achievable for many families. Patients with a Health Savings Account (HSA) or Flexible Spending Account (FSA) can pay for IVF with pre-tax dollars, effectively saving 20 to 35 percent depending on the tax bracket.
In more than a decade of following patient experiences in fertility care, several recurring errors stand out:
Choosing where to undergo treatment is as consequential as choosing how to pay for it. California patients have abundant data available, and using it systematically produces better decisions.
The Society for Assisted Reproductive Technology (SART) publishes clinic-specific outcome data, and the CDC's ART report provides national comparisons. Rather than looking at a single headline number, examine live birth rates broken down by age group and by whether the cycle used a patient's own eggs, then compare clinics treating similar patient profiles. Ask each clinic directly: how many cycles did you perform last year, what is your rate of cycles canceled before retrieval, and what is your average number of embryos transferred?
The embryology laboratory is the heart of any IVF program. Questions worth asking include whether the lab maintains its own on-site embryologists or shares services, whether it offers time-lapse embryo imaging, and what its vitrification (freezing) survival rates are. A clinic willing to discuss lab metrics in detail is usually one confident in them.
Patients consistently report that the quality of financial counseling predicts their overall satisfaction more than almost any other factor. Before committing, request a written, itemized estimate for your specific protocol, ask whether the clinic employs dedicated financial coordinators, and note how quickly the office responds to billing questions. A transparent billing process is a strong signal of a well-run practice.
Stimulation cycles require six to ten early-morning monitoring visits over roughly two weeks. For patients who work or live far from the clinic, satellite monitoring locations or partnerships with local providers can make the difference between a manageable cycle and an exhausting one.
The following established programs illustrate the range of options across the state. This is not an endorsement or ranking; each center has distinct characteristics, and patients should verify current pricing, services, and outcomes directly.
With locations in Encino, Pasadena, Newport Beach, and other cities, HRC Fertility is one of the larger networks in Southern California and is known for high cycle volume and published outcome data across age groups. Its size allows it to offer multi-cycle guarantee programs, and its multiple sites give patients flexibility in where monitoring occurs. It is frequently part of price comparisons for patients in the Los Angeles and Orange County areas.
CCRM operates centers in the San Francisco Bay Area, Newport Beach, and San Diego, with an emphasis on its in-house laboratory science and treatment of complex cases, including patients with recurrent implantation failure and diminished ovarian reserve. Its model centers on full-time embryology teams and genetic testing workflows. Pricing tends to sit at the higher end of the state range, which patients should weigh against the program's depth in challenging diagnoses.
Affiliated with the Keck School of Medicine of USC, this program combines academic medicine with a relatively boutique patient experience. It is a reasonable option for patients who value physician-led continuity of care, on-site laboratory services, and integration with a broader university medical system for coexisting conditions such as endometriosis, fibroids, or cancer-related fertility preservation.
As part of the University of California, San Francisco, this center serves Northern California patients with a research-active clinical program and comprehensive diagnostic services. Academic affiliation means access to clinical trials, which can partially offset treatment costs for eligible participants. Patients in the Bay Area often compare UCSF with private Bay Area practices on both price and appointment availability.
Serving the Sacramento region and Northern California's inland communities, this practice is often cited by patients for transparent pricing structures and a more accessible fee schedule than coastal metro centers. For patients in Davis, Roseville, Elk Grove, and the Central Valley, it offers a geographically convenient alternative to Bay Area travel.
When contacting any of these or other programs, ask the same set of questions of each: total estimated cost for your specific diagnosis, what the quote includes and excludes, current SART-reported outcomes for your age group, financial program options, and estimated time to treatment start. Consistent questions produce comparable answers.
Consider a hypothetical 34-year-old patient in Irvine with unexplained infertility and no insurance coverage for treatment. A plausible 2026 budget might look like this:
| Item | Estimated Cost |
|---|---|
| Diagnostic workup and consultation | $1,200 |
| Base IVF cycle including retrieval and lab fees | $17,500 |
| Medications | $4,800 |
| ICSI and PGT-A on five embryos | $5,200 |
| Embryo freezing and storage | $1,200 |
| Frozen embryo transfer three months later | $4,000 |
| Estimated total, first complete cycle | ~$33,900 |
If the first transfer does not succeed but two tested embryos remain in storage, a second transfer costs only the FET fee plus monitoring—roughly $4,000 to $5,000—rather than repeating retrieval. This is precisely why genetic testing and freezing, despite their upfront cost, can be financially efficient over a full treatment journey for many patients.
While cost planning dominates the financial conversation, patients who prepare physically and emotionally tend to navigate the process with fewer complications and cancellations—both of which carry financial consequences.
Some clinics offer a modest discount (typically 3 to 5 percent) for prepayment, but patients should weigh this against financing options with favorable terms and against the flexibility of paying per stage. Never sacrifice the ability to switch clinics for a small upfront discount.
A common recommendation is to have funding for one full cycle plus one frozen transfer secured before beginning, with a plan—financing, benefits, or savings—for a possible second retrieval. Starting a cycle without a funding plan for contingencies is the most common source of treatment-related financial stress.
Not reliably. Pricing reflects overhead, location, and business model as much as quality. Some high-volume practices achieve strong outcomes at moderate prices, while some premium-priced programs serve complex patient populations. Always compare outcome data adjusted for age and diagnosis rather than price alone.
Occasionally. Some clinics reduce monitoring fees for self-pay patients or allow partial monitoring with outside providers. It costs nothing to ask, and financial coordinators at California clinics are generally accustomed to these conversations.
Yes. IVF is a qualifying medical expense for both accounts. Patients with an FSA should note the annual contribution limit and use-it-or-lose-it rule, while HSA funds roll over and can be accumulated in advance of treatment.
The cost of IVF in California in 2026 is substantial, but it is also more transparent and more insurable than at any point in the past. The combination of SB 600's expanded coverage for state-regulated group plans, maturing financing products, employer fertility benefits, and clinics that increasingly publish all-in pricing means patients who do their homework can enter treatment with realistic expectations rather than invoice shock.
The practical sequence is straightforward: verify insurance benefits in writing, obtain itemized quotes from at least two or three clinics near you, compare SART and CDC outcome data for your age group, price medications at multiple pharmacies, and build a budget that covers a complete journey—including a frozen transfer—rather than a single procedure. Patients who follow that sequence consistently report not only lower total costs but greater confidence at every stage of care. Fertility treatment is a significant investment, and like any significant investment, it rewards preparation, comparison, and a clear-eyed understanding of exactly what each dollar buys.
